Additionally, in cancer we and others observed that aberrant expression of DNMT1, DNMT3A, DNMT3B and histone deacetylases (HDAC) is involved in the inactivation process of RASSF1A [51,53,54,55,56]. Here, DNMT1 is linked to cancer.